Home LiteratureArticle Details
PMID: 1310161 Published · ppublish English Comment Editorial

Progress against rare and not-so-rare cancers.

The New England journal of medicine ·Vol. 326 ·No. 8 ·1992-02-20 ·Pages 563-5

Chabner BA, Friedman MA

Abstract

暂无摘要

MeSH Terms
Adenoma, Islet Cell/drug therapy Adrenal Gland Neoplasms/drug therapy Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carcinoma, Non-Small-Cell Lung/therapy Cisplatin/administration & dosage Combined Modality Therapy Doxorubicin/administration & dosage Fluorouracil/administration & dosage Humans Lung Neoplasms/therapy Streptozocin/administration & dosage
Chemicals
Streptozocin Doxorubicin Cisplatin Fluorouracil
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chabner B A
Friedman M A
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
DOI
10.1056/NEJM199202203260811
Published
1992-02-20
Pages
563-5
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 1310159
CommentOn
PMID: 1310160
External Links
PubMed source DOI: 10.1056/NEJM199202203260811 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2